On the one hand, digoxin, a drug targeting ATP1A1, has been shown to increase glucose tolerance in type 2 diabetes patients78, but on the other hand increase risk of psychosis81,94. This evidence concerns the gene ATP1A1 and type 2 diabetes mellitus.